Abstract:Objectives EGFR testing is a mandatory step before targeted therapy for non-small cell lung cancer patients. Combining some quantifiable features to establish a predictive model of EGFR expression status, break the limitations of tissue biopsy. Materials and Methods We retrospectively analyzed 1074 patients of non-small cell lung cancer with complete reports of EGFR gene testing. Then manually segmented VOI, captured the clinicopathological features, analyzed traditional radiology features, and extracted radiomic, and deep learning features. The cases were randomly divided into training and test set. We carried out feature screening; then applied the light GBM algorithm, Resnet-101 algorithm, logistic regression to develop sole models, and fused models to predict EGFR mutation conditions. The efficiency of models was evaluated by ROC and PRC curves. Results We successfully established Model clinical , Model radiomic , Model CNN (based on clinical-radiology, radiomic and deep learning features respectively), Model radiomic+clinical (combining clinical-radiology and radiomic features), and Model CNN+radiomic+clinical (combining clinical-radiology, radiomic, and deep learning features). Among the prediction models, Model CNN+radiomic+clinical showed the highest performance, followed by Model CNN , and then Model radiomic+clinical . All three models were able to accurately predict EGFR mutation with AUC values of 0.751, 0.738, and 0.684, respectively. There was no significant difference in the AUC values between Model CNN+radiomic+clinical and Model CNN . Further analysis showed that Model CNN+radiomic+clinical effectively improved the efficacy of Model radiomic+clinical and showed better efficacy than Model CNN . The inclusion of clinical-radiology features did not effectively improve the efficacy of Model radiomic . Conclusions Either deep learning or radiomic signature-based models can provide a fairly accurate non-invasive prediction of EGFR expression status. The model combined both features effectively enhanced the performance of radiomic models and provided marginal enhancement to deep learning models. Collectively, fusion models offer a novel and more reliable way of providing the efficacy of currently developed prediction models, and have far-reaching potential for the optimization of noninvasive EGFR mutation status prediction methods.

RadGenNets: Deep Learning-Based Radiogenomics Model For Gene Mutation Prediction In Lung Cancer

Hand-Crafted and Deep Learning-Based Radiomics Models for Recurrence Prediction of Non-Small Cells Lung Cancers

Deep-Learning-Based Predictive Imaging Biomarker Model for EGFR Mutation Status in Non-Small Cell Lung Cancer from CT Imaging

Predictive radiogenomics modeling of EGFR mutation status in lung cancer

Deep learning for predicting epidermal growth factor receptor mutations of non-small cell lung cancer on PET/CT images

Machine Learning-Based Radiomics Signatures for EGFR and KRAS Mutations Prediction in Non-Small-Cell Lung Cancer

Predicting Gene Comutation of EGFR and TP53 by Radiomics and Deep Learning in Patients With Lung Adenocarcinomas

CT-based non-invasive identification of the most common gene mutation status in patients with non-small cell lung cancer

A Radiogenomics Pipeline for Lung Nodules Segmentation and Prediction of EGFR Mutation Status from CT Scans

Deep Learning to Predict EGFR Mutation and PD-L1 Expression Status in Non-Small-Cell Lung Cancer on Computed Tomography Images

Deep learning–radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients

Advancing EGFR mutation subtypes prediction in NSCLC by combining 3D pretrained ConvNeXt, radiomics, and clinical features

Hybrid Deep Multi-Task Learning Radiomics Approach for Predicting EGFR Mutation Status of Non-Small Cell Lung Cancer in CT Images.

Next Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Approaches

Using stacked deep learning models based on PET/CT images and clinical data to predict EGFR mutations in lung cancer

Convolutional Neural Networks For Predicting Molecular Profiles Of Non-Small Cell Lung Cancer

An Explainable Radiogenomic Framework to Predict Mutational Status of KRAS and EGFR in Lung Adenocarcinoma Patients

Three-Dimensional Convolutional Neural Network-Based Prediction of Epidermal Growth Factor Receptor Expression Status in Patients With Non-Small Cell Lung Cancer

Reliable Gene Mutation Prediction in Clear Cell Renal Cell Carcinoma through Multi-classifier Multi-objective Radiogenomics Model

Prediction of oncogene mutation status in non-small cell lung cancer: A systematic review and meta-analysis with a special focus on artificial-intelligence-based methods

Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning